The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
about
Single nucleotide polymorphisms in DNA repair genes and prostate cancer riskEndostatin gene variation and protein levels in breast cancer susceptibility and severity.No association between variant DNA repair genes and prostate cancer risk among men of African descent.Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells.Using high-density DNA methylation arrays to profile copy number alterations.Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.Contribution of HOGG1 Ser³²⁶Cys polymorphism to the development of prostate cancer in smokers: meta-analysis of 2779 cases and 3484 controls.Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects.Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-AnalysisGSTT1 polymorphism and the risk of developing prostate cancer.GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects.An update analysis of two polymorphisms in encoding ribonuclease L gene and prostate cancer risk: involving 13,372 cases and 11,953 controls.Arg462Gln and Asp541Glu polymorphisms in ribonuclease L and prostate cancer risk: a meta-analysismiR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.Susceptibility of XPD and hOGG1 genetic variants to prostate cancer.RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.Association of a common genetic variant in RNASEL and prostate cancer susceptibility.The RNASEL -1385G/A polymorphism is associated with risk of prostate cancer in Africans.hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population.
P2860
Q28383002-2A5E66CF-D880-4562-9BA3-6D9DAEDF5F8BQ33288626-2EFC4FA1-86A0-40C7-9B07-DC54CA984A05Q33560632-9275E900-836F-43D6-A45F-8BA882218A56Q33598877-FD8FB6CF-BC8A-4DBE-8676-EE279516F1E9Q33742976-F85138CD-3948-4647-9D41-D9BD0DABCE76Q33774556-29BAA724-1EB7-4049-A2BA-DBF7E55FA5FCQ34018442-B318BAEA-9993-490B-8B5D-4F678A689B43Q34082783-36607E99-B059-4AD2-9D05-CA243936C282Q34141776-EAD1C342-95D6-413A-950F-41DEC3651FC8Q34252079-0E1E8B5E-9E3B-487C-9DA9-72F2F5B6AD24Q34568211-3DE132DD-2917-4378-982F-D28EA3DF3400Q34793249-1A458F27-B0DA-4227-AFE3-D21EBE766B65Q35183316-3805DB97-6A36-4075-8FD3-C080D064C795Q37290556-41809C20-1C79-499B-90F6-76720AC1AE19Q38770707-1EED65AC-9FB3-4C65-A272-399EA3A653FDQ41161926-6A770845-1ACD-403D-AC11-8DDD1A54C0F4Q41232479-705D7DF7-63DD-4B88-B946-B0E2BF143A9AQ41928530-EADD31AD-FA36-4F13-B869-322B255F1732Q44895615-B6031653-012B-4FCC-AD15-6DACDF68FB3BQ46949052-825D8FD6-9014-40D2-899C-E43A6BF17F74Q47661684-1B531DE6-C43E-4BE4-B28C-41394CA5B8CDQ53289189-BA605C7B-D6D9-4745-928E-4A50F94BBD4B
P2860
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@en
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@nl
type
label
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@en
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@nl
prefLabel
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@en
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@nl
P2093
P1476
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
@en
P2093
Joan Sweet
John Trachtenberg
Laurence H Klotz
Linda Sugar
Marjan Emami
Michael A S Jewett
Robert K Nam
William W Zhang
P304
P356
10.1158/1078-0432.CCR-05-1226
P407
P577
2005-12-01T00:00:00Z